Skip to search formSkip to main contentSkip to account menu

oxdralazine

Known as: 3-(bis(2-hydroxyethyl)amino)-6-hydrazinopyridazine, 6-(bis(2-hydroxyethyl)amino)-3(2H)-pyridazinone, hydrazone, hydrazinopyridazine 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
The metal complexing properties of two antihypertensive drugs, hydralazine (1-hydrazinophthalazine) and prizidilol (a… 
2004
2004
SummaryThe effects of endralazine, a new antihypertensive hydrazinopyridazine derivative, on heart rate, mean blood pressure (mBP… 
1990
1990
1. Cadralazine is a new antihypertensive agent which causes peripheral vasodilation, probably mediated by a hydrazinopyridazine… 
1983
1983
After an initial placebo period of four weeks 24 patients with primary hypertension were treated with prizidilol, a… 
1983
1983
Abstract: Twenty‐nine moderate and severe essential hypertensive patients completed a crossover study aimed at evaluating… 
1980
1980
Oxdralazine, a pyridazine shown to induce prolonged arteriolar dilation in animals, was given orally in doses of 15 to 30 mg to 7… 
1979
1979
Forty-three patients suffering from hypertension of different origin (chronic renal failure, gout, or idiopathic) were treated… 
1979
1979
56 moderate and severe hypertensive patients entered an open long-term trial aimed at evaluating the efficacy and tolerability of… 
1978
1978
SummaryAn analysis of the correlations between acute changes in blood pressure and renal function elicited by antihypertensive…